Royce & Associates’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-500,623
Closed -$24.4M 1005
2022
Q1
$24.4M Sell
500,623
-321,078
-39% -$14.4M 0.21% 124
2021
Q4
$34.3M Buy
821,701
+179,066
+28% +$7.51M 0.26% 93
2021
Q3
$27.3M Buy
642,635
+367,260
+133% +$16.5M 0.2% 132
2021
Q2
$13.7M Buy
+275,375
New +$14.6M 0.09% 363
2020
Q3
Sell
-12
Closed 1197
2020
Q2
$0 Buy
+12
New +$462 ﹤0.01% 1242
2020
Q1
Sell
-15
Closed -$1K 1206
2019
Q4
$1K Sell
15
-11
-42% -$565 ﹤0.01% 1136
2019
Q3
$1K Hold
26
﹤0.01% 1149
2019
Q2
$1K Buy
+26
New +$1.39K ﹤0.01% 1153

Other funds holding CDK

Royce & Associates's CDK Position: Q2 2022 in Review

Royce & Associates sold out of CDK Global, Inc. (CDK) in Q2 2022, closing a stake of 500,623 shares — an estimated $24.4M sold.

Royce & Associates first reported a position in CDK in Q2 2019 and held it in 8 quarters. The position peaked at $34.3M in Q4 2021. 456 funds tracked by Wall St. Rank hold CDK as of Q2 2022.

  • Royce & Associates reported no remaining CDK Global, Inc. position as of Q2 2022 after selling out during the quarter.
  • Royce & Associates sold 500,623 CDK Global, Inc. shares in Q2 2022, an estimated $24.4M.
  • Royce & Associates first reported a position in CDK Global, Inc. in Q2 2019 and held it in 8 quarters.
  • Royce & Associates's CDK Global, Inc. position peaked at $34.3M in Q4 2021.
  • 456 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q2 2022.

Based on Royce & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.